Subscribe to MDT Magazine News

Drug Approved to Help Prevent Preterm Birth

February 4, 2011 8:45 am | by The Associated Press | Comments

-- Makena (hydroxyprogesterone caproate) has been approved by the U.S. Food and Drug Administration to help prevent birth before 37 weeks of pregnancy in women who have had at least one prior early delivery.Makena, however, is not intended for women who are at greater-than-average risk for...

Atlanta Company Pioneers Medical Devices with Georgia Tech Help

February 4, 2011 8:37 am | by Georgia Tech Institute of Technology | Comments

An Atlanta medical device company that is based on Georgia Tech research has become an industry rising star, with a new product moving toward approval -- and more than 65 employees.

Call for Papers: North American Universities Invited to Compete for 2011 Italian Machine Tool Technology Awards

February 4, 2011 8:36 am | by Society of Manufacturing Engineers | Comments

CHICAGO, Ill. DEARBORN, Mich., February 6, 2011 — A “Call for Papers” for the 2011 Italian Machine Tool Technology Awards (IMTTA) is announced by the Italian Trade Commission via its Chicago USA Office (ITC –, and its partners. More


FABTECH Shifts Show Dates to November 14-17

February 4, 2011 8:35 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., February 3, 2011 — FABTECH show management announced a shift in dates for FABTECH 2011. North America's largest metal forming, fabricating, welding and finishing event will now open on Monday, November 14 and run through Thursday, November 17 at Chicago's McCormick...

Tenet announces deal with Pa. health care plan

February 4, 2011 7:45 am | by The Associated Press | Comments

Two hospitals operated by Tenet Healthcare will have Medicaid and children's health insurance programs operated by UnitedHealthcare Community Plan of Pennsylvania under an agreement announced Friday.The terms of the deal were not disclosed. Tenet said the agreement will last for multiple...

Sirona boosts outlook after 1Q profit climbs

February 4, 2011 7:45 am | by The Associated Press | Comments

Sirona Dental Systems Inc. said Friday its profit jumped 36 percent in the fiscal first quarter, and the dental equipment maker's shares surged as the company raised its full-year guidance.Sirona said its profit rose to $42.4 million, or 75 cents per share, in the three months ended Dec. 31....

Heavyweights from the Primes, DoD and NASA to Address Challenges for Aerospace and Defense Manufacturers Under Today's Tight Budgets

February 4, 2011 7:36 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., February 3, 2011 — The senior-most executives from aerospace and defense manufacturing are gathering this spring at AeroDef 2011 Manufacturing Exposition and Conference to address the challenges facing the major OEMs and their supply chains, under pressure to...

58% of Physicians Support FDA Move to Pull Breast Cancer Indication from Avastin

February 4, 2011 7:35 am | by Bio-Medicine.Org | Comments

CAMBRIDGE, Mass., Feb. 4, 2011 /- Sermo ( ), the world's largest online community for physicians, announced the publication of a free Sermo Report about how physicians are reacting to the FDA decision to rescind the indication for Avastin (bevacizumab) in the...


Photocure Announces Positive Allumeraâ„¢ Trial Results for Delivering Significant Skin Appearance Improvements

February 4, 2011 7:35 am | by Bio-Medicine.Org | Comments

OSLO, Norway, Feb. 4, 2011 /- Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused in dermatology and cancer, today announced positive results from its consumer trial with Allumera™, a breakthrough cosmetic treatment formulated to improve the skin's appearance....


Earnings Preview: Humana reports 4Q earnings

February 4, 2011 6:45 am | by The Associated Press | Comments

Health insurer Humana Inc. reports fourth-quarter financial results on Monday before the market opens.WHAT TO WATCH FOR: Humana said late last year that its forecast for 2011 earnings would slip by about a dollar per share from the prior year due mainly to less favorable trends for its crucial...

R.I. council awards $1.4M to eight projects

February 4, 2011 6:36 am | by Mass High Tech: The Journal of New England Technology | Comments

The Rhode Island Science and Technology Advisory Council (STAC) has singled out eight research projects and 23 scientists from 13 institutions for a total of $1.4 million in grants.

Avecia Biotechnology acquired by Japanese firm

February 4, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Avecia Biotechnology Inc., a DNA- and RNA-based therapeutics firm in Milford, has been acquired by Japanese materials manufacturer Nitto Denko Corp.

Federal Register: Industry Exchange Workshop on Food and Drug Administration Drug and Device Requirements; Public Workshop

February 4, 2011 5:30 am | by U.S. Food & Drug Administration | Comments

This 2-day public workshop is intended to provide information about FDA drug and device regulation to the regulated industry.


MEDfx to Harmonize the Direct Project With CONNECT

February 4, 2011 4:35 am | by Bio-Medicine.Org | Comments

WARWICK, R.I., Feb. 4, 2011 /- MEDfx Corporation today announced a Direct Project pilot that demonstrates health information exchange among providers using a combination of the standards and protocols supported by the Direct Project and the FHA CONNECT Gateway. MEDfx is participating in,...


FDA Approves Makenaâ„¢, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm ...

February 4, 2011 4:33 am | by Bio-Medicine.Org | Comments

ST. LOUIS, Feb. 4, 2011 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a specialty pharmaceutical company, announced today that it has been informed by Hologic, Inc. that the U.S. Food and Drug Administration (FDA) granted approval for Makena™ (hydroxyprogesterone...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.